{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:31:50Z","timestamp":1787729510878,"version":"build-2784847793"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-019-6668-6","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T01:48:41Z","timestamp":1553824121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Evaluating progress towards triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B in the Netherlands"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2607-7677","authenticated-orcid":false,"given":"Maartje","family":"Visser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina P. B.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal W. P. M.","family":"Hukkelhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frithjofna","family":"Abbink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit H. B.","family":"van Benthem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline L. M.","family":"Op de Coul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"key":"6668_CR1","unstructured":"National Institute for Public Health and the Environment, Centre for Population Screening. Draaiboek Prenatale Screening Infectieziekten en Erythrocytenimmunisatie [in Dutch]. Version 6.0, April 2018."},{"key":"6668_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1471-2334-11-185","volume":"11","author":"EL Coul Op de","year":"2011","unstructured":"Op de Coul EL, Hahne S, van Weert YW, Oomen P, Smit C, van der Ploeg KP, et al. Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective. BMC Infect Dis. 2011;11:185.","journal-title":"BMC Infect Dis"},{"key":"6668_CR3","volume-title":"Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis. Second edition","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis. Second edition, 2017."},{"key":"6668_CR4","unstructured":"World Health Organization. The Global Health Sector Strategy on Viral Hepatitis 2016\u20132021, June 2016."},{"key":"6668_CR5","unstructured":"Van der Ploeg CPB, Sch\u00f6nbeck Y, Oomen P, Vos K. Prenatale screening Infectieziekten en Erythrocyten-immunisatie (PSIE). Procesmonitor 2015 [in Dutch]. TNO\/RIVM (Netherlands Organisation for Applied Scientific Research TNO \/ National Institute for Public Health and the Environment);2017."},{"key":"6668_CR6","volume-title":"Perinatale Zorg in Nederland 2015 [in Dutch]","author":"Perined","year":"2016","unstructured":"Perined. Perinatale Zorg in Nederland 2015 [in Dutch]. Utrecht: Perined; 2016."},{"key":"6668_CR7","unstructured":"Van Lier EA, Geraedts JLE, Oomen PJ, Giesbers H, Van Vliet JA, Drijfhout IH, et al. Vaccinatiegraad en jaarverslag Rijksvaccinatieprogramma Nederland 2017 [in Dutch]. RIVM; 2018. Report No.: 2018-0008."},{"key":"6668_CR8","unstructured":"Van der Ploeg CPB, Sch\u00f6nbeck Y, Oomen P, Vos K. Prenatale Screening Infectieziekten en Erytrocytenimmunisatie (PSIE). Procesmonitor 2016 [in Dutch]. TNO\/RIVM (Netherlands Organisation for Applied Scientific Research TNO \/ National Institute for Public Health and the Environment); 2018."},{"key":"6668_CR9","unstructured":"Van Lier EA, Geraedts JLE, Oomen PJ, Giesbers H, van Vliet JA, Drijfhout IH, et al. Vaccinatiegraad en jaarverslag rijksvaccinatieprogramma Nederland 2016 [in Dutch]. Bilthoven: National Institute for Public Health and the Environment; 2017. Report No.: 2017\u20130010."},{"key":"6668_CR10","unstructured":"Nederlandse Vereniging van Hiv Behandelaren. Richtlijn HIV: 2.1. Wanneer beginnen? \n                    http:\/\/richtlijnhiv.nvhb.nl\/index.php\/2.1._Wanneer_beginnen%3F\n                    \n                  . Accessed 10 Dec 2018."},{"issue":"24","key":"6668_CR11","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324\u201334.","journal-title":"N Engl J Med"},{"key":"6668_CR12","unstructured":"van Heiningen FM, Wijnands YHHM, Veldhuijzen IK, Hahn\u00e9 SJM. Verbeterslag nodig in de uitvoering van hepatitis B-serologie bij kinderen van moeders met chronische hepatitis B [in Dutch]. Infectieziektenbulletin. 2016;27(4):3."},{"issue":"1","key":"6668_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/1471-0528.13950","volume":"124","author":"I Simms","year":"2017","unstructured":"Simms I, Tookey PA, Goh BT, Lyall H, Evans B, Townsend CL, et al. The incidence of congenital syphilis in the United Kingdom: February 2010 to January 2015. BJOG. 2017;124(1):72\u20137.","journal-title":"BJOG."},{"issue":"4","key":"6668_CR14","first-page":"527","volume":"64","author":"H Peters","year":"2017","unstructured":"Peters H, Francis K, Sconza R, Horn A, C SP, Tookey PA, et al. UK mother-to-child HIV transmission rates continue to decline: 2012-2014. Clin Infect Dis. 2017;64(4):527\u20138.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"6668_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002329","volume":"14","author":"M Taylor","year":"2017","unstructured":"Taylor M, Newman L, Ishikawa N, Laverty M, Hayashi C, Ghidinelli M, et al. Elimination of mother-to-child transmission of HIV and syphilis (EMTCT): process, progress, and program integration. PLoS Med. 2017;14(6):e1002329.","journal-title":"PLoS Med"},{"key":"6668_CR16","volume-title":"Sexually Transmitted Disease Surveillance 2017","author":"Centre for Infectious Disease Control and Prevention","year":"2018","unstructured":"Centre for Infectious Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2017. Atlanta: Department of Health and Human Services; 2018."},{"key":"6668_CR17","doi-asserted-by":"crossref","unstructured":"Furegato M, Fifer H, Mohammed H, Simms I, Vanta P, Webb S, et al. Factors associated with four atypical cases of congenital syphilis in England, 2016 to 2017: an ecological analysis. Euro Surveill. 2017;22(49).","DOI":"10.2807\/1560-7917.ES.2017.22.49.17-00750"},{"key":"6668_CR18","unstructured":"Van der Ploeg CPB, Sch\u00f6nbeck Y, Hirschberg H, Oomen P. Prenatale Screening Infectieziekten en Erythrocyten-immunisatie (PSIE). Procesmonitor 2014 [in Dutch]. TNO\/RIVM (Netherlands Organisation for Applied Scientific Research TNO \/ National Institute for Public Health and the Environment); 2016."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6668-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-6668-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6668-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T20:07:42Z","timestamp":1585339662000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-6668-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6668"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-6668-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]},"assertion":[{"value":"12 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data from Osiris, the national registry for notifiable diseases at the RIVM, are anonymously collected as a legal obligation enforced by the Dutch public health act and International Health Regulations by the World Health Organisation and can be used for surveillance research. The ATHENA cohort was approved by the institutional board from all participating HIV treatment centres and patient consent is received by opting out. Data are pseudonymised and may be used for scientific purposes. The Praeventis pregnancy screening data are collected based on patient informed consent, and anonymised when used for research purposes. Data from Perined and the IDS laboratory were received as aggregated data. Additional approval by an ethical committee was for this study not necessary according to the Dutch Medical Research (involving Human Subjects) Act, as the study used only previously collected data (Wet medisch-wetenschappelijk onderzoek met mensen, 1998 \u00a71 artikel 1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"353"}}